{
    "2021-01-27": [
        [
            {
                "time": "2021-02-04",
                "original_text": "Novartis (NVS) Misses on Q4 Earnings, Issues Grim 2021 Outlook",
                "features": {
                    "keywords": [
                        "Novartis",
                        "Q4 Earnings",
                        "Misses",
                        "Grim Outlook"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-02-04",
                "original_text": "Novartis (NVS) Q4 2020 Earnings Call Transcript",
                "features": {
                    "keywords": [
                        "Novartis",
                        "Q4 2020",
                        "Earnings Call",
                        "Transcript"
                    ],
                    "sentiment_score": 0.0,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}